UAEM in the Media

GENERAL PRESS COVERAGE:

 

Intellectual Property Watch
January 25th, 2017

The Medicines Patent Pool announced today that it has signed a license agreement with Johns Hopkins University for a candidate tuberculosis treatment. Although seen as a major step forward by public health groups, they said the agreement does not include guarantees that the treatment that could be brought to the market would be affordable for all.

 

Infojustice.org
January 23rd, 2017

The six candidates for Director-General of the World Health Organization (WHO) – of whom one will be elected this May – have published responses to an open letter asking them to make clear their plans for the future of the WHO’s work in promoting a new system of equitable drug R&D. The original open letter was signed by 18 civil society organizations, and titled “Will you support a patient-centred R&D agreement?“.

 

Intellectual Property Watch
January 19th, 2017

A range of civil society organisations have issued a public statement opposing the United States Army’s proposed grant of an exclusive licence on technology necessary to produce a Zika vaccine to French pharmaceutical company Sanofi.

 

CWRUMed360
January 2017
Gloria “Tavera, 29 years old, was recognized for her work, beginning in 2005, as a member, board member, and current president of the North American board of Universities Allied for Essential Medicines. The international nonprofit student-driven organization, established in 2001, works to make vital medicines available to patients in countries where they cannot afford them. It has more than 100 chapters at universities in nearly 20 countries.”

Forbes 
January 2017

“If universities use federal funds to help invent new medicines, shouldn’t they also push to make sure people who need those medicines get them? That’s the idea behind Universities Allied for Essential Medicines. Tavera, now an M.D./Ph.D. student at Case Western Reserve University, is a founding member and the current president of the organization, which has 100 chapters at universities in 18 different countries.”

 

The Plain Dealer
January 10th, 2017
“Others on the list include Gloria Tavera, a medical science training candidate at Case Western Reserve University School of Medicine”… “a founding member and the current president of Universities Allied for Essential Medicines, a global network of university students who believe universities have a responsibility to improve global access to public health goods.”

 

Huffington Post – UAEM India
November 12th, 2016
“Last year, more than 450 academics, including four Nobel laureates, joined Universities Allied for Essential Medicines (UAEM)’s call for this R&D reform, in a letter to the World Health Organisation. In spite of the profit-driven motives of many Big Pharma-allied representatives from the United States and certain European countries, countries like Brazil, India, and Thailand are still making efforts to move forward with the UNHLP recommendations.”


Rahma Wiryomartono
October 31st, 2016

If the McGill chapter’s motion passes on November 7 at the GA, the motion will push the University to “adopt an open access framework for all future medicine patents created at McGill and sold to the private sector.”…..

 

Prottusha Sarkar, Contributing Reporter
November 11th, 2016

UAEM advocates for access to medicine in many ways, with a few specific student chapter-led campaigns and projects. One campaign, called “Take Back Our Meds,” targets“the National Institutes of Health (NIH) … to ensure that the research they fund at universities [that] leads to a product being developed” is made accessible and affordable to patients both domestically and abroad…..

 

Common Dreams
July 25th, 2016

Other98 and allies from Social Security Works, Act Up, and Universities Allied for Essential Medicines have teamed up to create an infotaining new website……featuring a series of text message exchanges between a fictional (but accurate) Pharma CEO and everyman John Doe.

 

Joe My God
July 25th, 2016

Activists targeted candidate Clinton for her refusal to renew her 2008 campaign pledges to regulate the price-gouging of medicines made by major pharmaceutical companies……… The high prices make it hard for people with HIV as well as other people to access the lifesaving treatment they need.

 

Commonweal Magazine
June 28th, 2016

This current system is very well-designed to do exactly what it does: create maximum profits for pharmaceutical companies. And it has been incredibly resilient to every challenge we make to it.

 

IP:WATCH
May 26th, 2016

Public health advocates… had high hopes that this year’s [WHA] could finally agree on some alternative ways to fund [R&D] that can lead to affordable medical products by de-linking R&D costs from prices, through the long-awaited discussion of a landmark 2012 report of a WHO expert group [CEWG] on medical R&D.

 

Consumer Groups Object to FDA Reforms in Cures Bill
Bloomberg BNA
May 19th, 2016

Thirteen consumer and patient groups May 18 warned members of a Senate committee not to insert proposals in their version of the 21st Century Cures Act that would undermine patient safety and curb access to lifesaving treatments.

 

Public Health Advocates Urge WHO Action on R&D Financing for the Poor
IP:WATCH
May 12th, 2016

Public health advocates last week told World Health Organization delegates they must act quickly to save the lives of poor populations suffering from less common diseases for which there is no research and development funding.

 

IP:WATCH
February 25th, 2016

Re:Route, a mapping tool that lays out the research and development (R&D) landscape of innovation and financing for medicines, has been launched by the Universities Allied for Essential Medicines (UAEM). It is a one-stop place for the alternative biomedical research and development landscape.

 

IP:WATCH
November 13th, 2015
In a big action campaign, students worldwide turned the spotlight on shortcomings of the global R&D system. With the second edition of its Access to Medicines Week, UAEM called on the scientific community in an open letter to support a global research agreement.

 

The Huffington Post
May 21st, 2015
We are writing from the 68th World Health Assembly, where a drafting group of Member States are discussing the Framework of Engagement With Non-State Actors (FENSA).

 

International Coverage:

 

Investigadores y estudiantes se unen para pedir un Acuerdo Global sobre I+D a la OMS y los Estados Miembros

Diario Medico
6 Noviembre 2015
Estudiantes e investigadores piden un pacto mundial para el acceso asequible a fármacos.

 

Investigadores y estudiantes se unen para pedir un Acuerdo Global sobre I+D a la OMS y los Estados Miembros [Spain; RADIO]

Canal Medico
10 Noviembre 2015
Científicos e investigadores están firmando una carta abierta dirigida a la Organización Mundial de la Salud (OMS) y a los Estados miembros, pidiendo un Acuerdo global sobre I+D.

 

Studierendeninitiative: Sozial verantwortlich forschen [Germany]

Dtsch Arztebl
2015
Die Organisation „Universities Allied for Essential Medicines“ macht das geltende Patentsystem für überhöhte Preise und damit für Zugangshürden zu medizinischen Innovationen verantwortlich. Sie plädiert für alternative Forschungsanreize.

 

Studerende kæmper globalt for billigere medicin [Denmark; RADIO]

VIDEN
3 November 2015
International studenterorganisation vil presse verdens lande til at støtte FN-løsning, der afskaffer medicin-patenter og øger forskning i infektionssygdomme.

 

Report Card Media Coverage in 2015:

 

University Grades Are Mixed on Research for the Poor

The New York Times
May 11th, 2015
For the second time, American universities have been ranked by how well they do global health research. This time only one — Johns Hopkins — earned a grade as high as A minus.

 

Holding Universities Accountable for their role in advancing biomedical research which addresses neglected health needs

The Lancet Global Health Blog
April 20th, 2015
The University Report Card: Global Equity and Biomedical Research… serves as an advocacy tool for universities to assess their own progress in investing in innovative medical research that addresses global neglected health needs, as well as focusing on the core role of universities in terms of transforming innovation and access for all.

 

Not free vaccines, Mr Gates, just sustainably-priced ones

The Lancet Global Health Blog
March 19th, 2015
We believe that a system dependent on raising massive amounts of money to meet arbitrarily high prices set by the pharmaceutical industry is a failed system………. true sustainable vaccine pricing.

 

Additional 2015 Articles:

Baltimore Sun
Advisory Board Company
Policy Innovations
UCSD’s San Diego Union Tribune
Johns Hopkins Center for Global Health
Johns Hopkins Hub
Boston University Daily Free Press
IP Watch
The Huffington Post
The Daily Pennsylvanian

 

Report Card Media Coverage in 2013:

The New York Times
BMJ (British Medical Journal)
The Lancet
Interpress Service News Agency
The Chronicle of Higher Education
The Toronto Star
The Kaiser Family Foundation
IP Watch
Humanosphere
University of Florida Alligator
The Daily Iowan
University of British Columbia
The Vancouver Sun
The University of Alberta Gateway
The Boston University Daily Free Press
The Duke Chronicle–News
Triangle Business Journal
The Duke Chronicle–Editorial
The Times of India
The University of Minnesota, Twin Cities, Minnesota Daily
News 1130
New York University’s Washington Square News
The Marquette Tribune
Minnesota Public Radio on Campus
The Dartmouth Daily
The Pitt News
Georgetown University O’Neill Institute

 

Comments are closed.